Patents by Inventor Lin Hao

Lin Hao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11885804
    Abstract: The invention relates to the application of the ERH gene in the preparation of bladder cancer diagnosis and treatment products. The ERH gene is found to have a good correlation with bladder cancer. In addition, an RNA interference vector is constructed to perform cell function experiments to study the effect of ERH gene on the proliferation and clonality of bladder cancer cells. The present invention provides a research basis for clinical diagnosis and treatment of bladder cancer and has a good application prospect.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: January 30, 2024
    Assignee: XUZHOU CENTRAL HOSPITAL
    Inventors: Conghui Han, Qian Lv, Kun Pang, Lin Hao, Ying Liu
  • Publication number: 20220370538
    Abstract: A method for extracting functional ingredients of mulberry leaves using enzyme is provided. A method for preparing crude cellulase enzyme solution and crude pectinase enzyme solution includes: preparing PDA slant culture mediums; preparing fermentation mediums for producing cellulase and pectinase; preparing solid bacteria; fermentation; preparing crude cellulase enzyme solution and crude pectinase enzyme solution. A preparation method of mulberry leaf concentrate is provided and includes: enzymatic hydrolysis, enzyme inactivation and concentration. A method for preparing mulberry leaf products from mulberry leaf concentrate is provided.
    Type: Application
    Filed: December 15, 2021
    Publication date: November 24, 2022
    Inventors: Lin Hao, Qianqian Li, Liping Hao
  • Publication number: 20220065859
    Abstract: The invention relates to the application of the ERH gene in the preparation of bladder cancer diagnosis and treatment products. The ERH gene is found to have a good correlation with bladder cancer. In addition, an RNA interference vector is constructed to perform cell function experiments to study the effect of ERH gene on the proliferation and clonality of bladder cancer cells. The present invention provides a research basis for clinical diagnosis and treatment of bladder cancer and has a good application prospect.
    Type: Application
    Filed: November 15, 2021
    Publication date: March 3, 2022
    Inventors: Conghui HAN, Qian LV, Kun PANG, Lin HAO, Ying LIU
  • Publication number: 20190339276
    Abstract: Provided herein are methods of applying the ERH gene in the preparation of bladder cancer diagnosis and treatment products. The ERH gene is found to have a good correlation with bladder cancer. In addition, an RNA interference vector is constructed to perform cell function experiments to study the effect of ERH gene on the proliferation and clonality of bladder cancer cells. The methods disclosed herein provide a research basis for clinical diagnosis and treatment of bladder cancer and has a good application prospect.
    Type: Application
    Filed: May 25, 2017
    Publication date: November 7, 2019
    Inventors: Conghui Han, Qian Lv, Kun Pang, Lin Hao, Ying Liu
  • Patent number: D946984
    Type: Grant
    Filed: December 30, 2019
    Date of Patent: March 29, 2022
    Inventor: Lin Hao